Health-Economic Evaluation of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir for Treatment of Chronic Genotype 1 Hcv Infection in Germany
Abstract
Authors
G Sroczynski A Conrads-Frank F Kühne N Mühlberger H Fröhlich B Dietz JC Samp S Zeuzem U Siebert